BRADBURY DANIEL 4
4 · CASTLE BIOSCIENCES INC · Filed Feb 7, 2025
Insider Transaction Report
Form 4
BRADBURY DANIEL
Director
Transactions
- Sale
Common Stock
2025-02-05$28.17/sh−1,425$40,147→ 0 total(indirect: By Trust) - Sale
Common Stock
2025-02-05$28.17/sh−5,017$141,344→ 0 total(indirect: By LLC) - Sale
Common Stock
2025-02-05$28.17/sh−1,425$40,147→ 0 total(indirect: By Trust)
Holdings
- 13,291(indirect: By Trust)
Common Stock
Footnotes (6)
- [F1]These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, Daniel Bradbury Irrevocable Descendant's Trust, and Annette Bradbury Irrevocable Descendant's Trust on May 10, 2024.
- [F2]This transaction was executed in multiple trades at prices ranging from $28.060 to $28.585, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares.
- [F4]Held by Daniel Bradbury Irrevocable Descendant's Trust of which the Reporting Person and his spouse are trustees and their children are beneficiaries.
- [F5]Held by Annette Bradbury Irrevocable Descendant's Trust of which the Reporting Person and his spouse are trustees and their children are beneficiaries.
- [F6]Held by Bradbury Family Trust of which the Reporting Person and Annette Bradbury are the trustees and the beneficiaries.